Sinibaldi-Vallebona P - Search Results

1

Induction of apoptosis in neoplastic cells by anthracycline antitumor drugs: nuclear and cytoplasmic triggering?

Serafino A, Sinibaldi-Vallebona P, Pierimarchi P, Bernard P, Gaudiano G, Massa C, Rasi G, Ranagnan G. Serafino A, et al. Anticancer Res. 1999 May-Jun;19(3A):1909-18. Anticancer Res. 1999. PMID: 10470135

2

Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats.

Rasi G, Silecchia G, Sinibaldi-Vallebona P, Spaziani E, Pierimarchi P, Sivilia M, Tremiterra S, Garaci E. Rasi G, et al. Int J Cancer. 1994 Jun 1;57(5):701-5. doi: 10.1002/ijc.2910570516. Int J Cancer. 1994. PMID: 8194879

3

Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B.

Rasi G, Mutchnick MG, Di Virgilio D, Sinibaldi-Vallebona P, Pierimarchi P, Colella F, Favalli C, Garaci E. Rasi G, et al. J Viral Hepat. 1996 Jul;3(4):191-6. doi: 10.1111/j.1365-2893.1996.tb00094.x. J Viral Hepat. 1996. PMID: 8871880 Clinical Trial.

4

Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C.

Rasi G, DiVirgilio D, Mutchnick MG, Colella F, Sinibaldi-Vallebona P, Pierimarchi P, Valli B, Garaci E. Rasi G, et al. Gut. 1996 Nov;39(5):679-83. doi: 10.1136/gut.39.5.679. Gut. 1996. PMID: 9026482 Free PMC article.

5

Cytoplasmic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms.

Serafino A, Sinibaldi-Vallebona P, Gaudiano G, Koch TH, Rasi G, Garaci E, Ravagnan G. Serafino A, et al. Anticancer Res. 1998 Mar-Apr;18(2A):1159-66. Anticancer Res. 1998. PMID: 9615782

6

Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesis.

Guadagni F, Graziano P, Roselli M, Mariotti S, Bernard P, Sinibaldi-Vallebona P, Rasi G, Garaci E. Guadagni F, et al. Am J Pathol. 1999 Apr;154(4):993-9. doi: 10.1016/S0002-9440(10)65351-5. Am J Pathol. 1999. PMID: 10233837 Free PMC article.

7

Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin-2 after intraperitoneal 5-fluorouracil delivery.

Silecchia G, Guarino E, Sinibaldi-Vallebona P, Pierimarchi P, Restuccia A, Spaziani E, Bernard P, Tuthill C, Garaci E, Rasi G. Silecchia G, et al. Cancer Immunol Immunother. 1999 Jul;48(4):172-8. doi: 10.1007/s002620050562. Cancer Immunol Immunother. 1999. PMID: 10431686 Free PMC article.

8

A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cells.

Rasi G, Sinibaldi-Vallebona P, Serafino A, Bernard P, Pierimarchi P, Guarino E, Faticanti-Scucchi L, Graziano P, Guadagni F, Garci E. Rasi G, et al. Int J Cancer. 2000 Feb 15;85(4):540-4. doi: 10.1002/(sici)1097-0215(20000215)85:4<540::aid-ijc16>3.0.co;2-v. Int J Cancer. 2000. PMID: 10699928

9

Combined treatment with thymosin-alpha1 and low dose interferon-alpha after dacarbazine in advanced melanoma.

Rasi G, Terzoli E, Izzo F, Pierimarchi P, Ranuzzi M, Sinibaldi-Vallebona P, Tuthill C, Garaci E. Rasi G, et al. Melanoma Res. 2000 Apr;10(2):189-92. Melanoma Res. 2000. PMID: 10803720 Clinical Trial. No abstract available.

10

Lack of glutathione conjugation to adriamycin in human breast cancer MCF-7/DOX cells. Inhibition of glutathione S-transferase p1-1 by glutathione conjugates from anthracyclines.

Gaudiano G, Koch TH, Lo Bello M, Nuccetelli M, Ravagnan G, Serafino A, Sinibaldi-Vallebona P. Gaudiano G, et al. Biochem Pharmacol. 2000 Dec 15;60(12):1915-23. doi: 10.1016/s0006-2952(00)00521-9. Biochem Pharmacol. 2000. PMID: 11108808

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters